Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. The company is headquartered in Melbourne, Victoria and currently employs 58 full-time employees. The firm is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. The firm offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The firm has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The firm's segments include EasyDNA and AffinityDNA. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses.
GNTLF stock price ended at $0 on 금요일, after dropping 100.00%
On the latest trading day Jul 25, 2025, the stock price of GNTLF fell by 100.00%, dropping from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. On the latest trading day, the trading volume for GNTLF rose by 1.9K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 2.0K shares were traded, with a market value of approximately --.
GNTLF 기술적 시그널
기술적 시그널 요약
구매 신호 0
중립 신호 7
매도 신호 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
GNTLF은 현재 0개의 매수 신호와 0개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 하락 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 -100%입니다. 전반적으로 기술적 지표들은 중기적으로 Neutral 전망을 나타내고 있습니다.
GNTLF에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 GNTLF 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.